Lv3
280 积分 2025-07-19 加入
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
1个月前
已完结
Comparing the patients’ subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires
1个月前
已关闭
Validity of functional patient-reported outcomes in head and neck oncology: A systematic review
1个月前
已完结
Patient‐reported outcomes in immunotherapy for head and neck cancer
1个月前
已关闭
Formamide Hydrolysis in Alkaline Aqueous Solution: Insight from Ab Initio Metadynamics Calculations
1个月前
已关闭
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
1个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant:A Randomized Clinical Trial
1个月前
已完结
Nivolumab plus ipilimumab with chemotherapy for non–small cell lung cancer with untreated brain metastases: a multicenter single-arm phase 2 trial (NIke, LOGiK 2004)
1个月前
已完结
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL Study
1个月前
已关闭
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression ≥25%: Results from the Randomized Phase 3 PEARL Study
1个月前
已关闭
皖公网安备34019202002308
